Skip to main content

Table 2 24-h CGM data of each HbA1c group

From: The relationship between HbA1c values and the occurrence of hypoglycemia as assessed by continuous glucose monitoring in patients with type 1 diabetes

HbA1c Group A
HbA1c ≤7.2 %
Group B
7.2 % <HbA1c ≤8.2 %
Group C Group D
HbA1c >9.2 %
P value
8.2 % <HbA1c ≤9.2 %
Mean glucose levels (mg/dL)a 133.0
(113.5‒154.8)
157.5
(131.5‒187.5)
182.0
(152.0‒206.0)
186.0
(143.0‒214.8)
<0.001
SDa 53.0
(40.0‒65.0)
53.5
(44.8‒69.8)
64.0
(55.0‒76.0)
58.0
(48.0‒80.0)
0.165
MAGE (mg/dL)a 99.3
(62.4–149.0)
99.7
(78.5–130.3)
103.3
(81.8–127.9)
89.8
(66.7–119.6)
0.783
%CV a 40.7
(32.8–51.2)
34.0
(30.8–45.1)
37.6
(30.1–41.0)
36.8
(27.1–45.6)
0.405
J-index a 38.7
(24.8–44.1)
51.0
(31.5–61.5)
64.7
(44.1–82.6)
65.2
(40.5–82.8)
<0.001
M value a 10.9
(6.7–20.2)
15.1
(7.6–18.3)
17.5
(10.3–29.9)
19.4
(9.6–27.4)
0.126
MODD (mg/dL)a 43.9
(31.3–54.4)
53.5
(41.8–64.1)
53.5
(39.7–89.6)
57.7
(41.0–81.4)
0.163
Time in hypoglycemia (min)a 170.0
(57.5‒341.3)
77.5
(0‒210.0)
45.0
(0‒105.0)
20.0
(0‒105.0)
0.014
Time in nocturnal hypoglycemia (min)a 120.0
(5.0‒268.8)
25.0
(0‒120.0)
0
(0‒60.0)
0
(0‒88.8)
0.019
LBGI a 5.7
(2.6–9.0)
3.6
(0.9–6.8)
3.9
(1.2–10.8)
2.2
(0.6–5.6)
0.162
Time in hyperglycemia (min)a 335.0
(147.5‒446.3)
457.5
(193.8‒722.5)
715.0
(425.0‒945.0)
675.0
(351.3‒953.8)
0.001
HBGI a 8.1
(5.4–9.3)
10.9
(6.0–13.8)
13.2
(8.4–19.4)
13.7
(6.6–20.4)
0.003
  1. Data presented as median (25–75 percentiles)
  2. Italic values indicate significance of P value (P < 0.05)
  3. aKruskal–Wallis test